Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 7403924643
SciProfiles: 1881577

Countries

United States

Activities

Collapse all

Employment (1)

The University of Texas MD Anderson Cancer Center: Houston, TX, US

2020-07-01 to present | Assistant Professor, Molecular Genetic Pathology (Pathology)
Employment
Source: Self-asserted source
Richard Yang

Education and qualifications (1)

University of Wisconsin Madison: Madison, WI, US

2006-06-06 to 2014-05-15 | MD, PhD (Institute for Clinical and Translational Research)
Education
Source: Self-asserted source
Richard Yang

Works (50 of 82)

Items per page:
Page 1 of 2

Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time

JCO Precision Oncology
2025-03 | Journal article
DOI: 10.1200/PO.24.00299
Contributors: Peng Wang; Richard Kenneth Yang; Fatima Zahra Jelloul; Rajyalakshmi Luthra; Mark J. Routbort; Hui Chen; Sanam Loghavi; Chi Young Ok; Rashmi Kanagal-Shamanna; Sinchita Roy-Chowdhuri et al.
Source: check_circle
Crossref

Melanoma With RNF11::BRAF Fusion: A Novel Fusion Previously Undescribed in Melanoma

The American Journal of Dermatopathology
2025-02-25 | Journal article
DOI: 10.1097/dad.0000000000002936
Part of ISSN: 0193-1091
Part of ISSN: 1533-0311
Contributors: Yan Gao; Richard K. Yang; Jonathan L. Curry; Carlos A. Torres-Cabala; Woo Cheal Cho
Source: Self-asserted source
Richard Yang

NSD3::FGFR1: A Novel Gene Fusion First to Be Described in Merkel Cell Carcinoma

The American Journal of Dermatopathology
2025-02-25 | Journal article
DOI: 10.1097/dad.0000000000002953
Part of ISSN: 0193-1091
Part of ISSN: 1533-0311
Contributors: Volha Lenskaya; Richard K. Yang; Phyu P. Aung; Victor G. Prieto; Priyadharsini Nagarajan; Woo Cheal Cho
Source: Self-asserted source
Richard Yang

Mitochondrial defects and metabolic vulnerabilities in Lynch syndrome-associated MSH2-deficient endometrial cancer.

JCI insight
2025-02-18 | Journal article
DOI: 10.1172/jci.insight.185946
PMID: 39964762
Contributors: Bowen MB; Melendez B; Zhang Q; Moreno D; Peralta L; Chan WK; Jeter C; Tan L; Zal MA; Lorenzi PL et al.
Source: Self-asserted source
Richard Yang

Gene Fusion-Driven Cutaneous Adnexal Neoplasms: An Updated Review Emphasizing Molecular Characteristics

The American Journal of Dermatopathology
2025-02-06 | Journal article
DOI: 10.1097/dad.0000000000002933
Part of ISSN: 0193-1091
Part of ISSN: 1533-0311
Contributors: Gerardo Cazzato; Maged Daruish; Francesco Fortarezza; Anna Colagrande; Andrea Marzullo; Giuseppe Ingravallo; Angelo Paolo Dei Tos; Richard K. Yang; Woo Cheal Cho
Source: Self-asserted source
Richard Yang

Same-day molecular testing for targetable mutations in solid tumor cytopathology-The next frontier of the rapid on-site evaluation.

Cancer cytopathology
2025-01-01 | Journal article
DOI: 10.1002/cncy.22930
PMID: 39746874
Contributors: Iorgulescu JB; Yang RK; Sinchita Roy-Chowdhuri; Sura GH
Source: Self-asserted source
Richard Yang

Microsatellite instability and high tumor mutational burden detected by next generation sequencing are concordant with loss of mismatch repair proteins by immunohistochemistry.

Cancer genetics
2024-12-15 | Journal article
DOI: 10.1016/j.cancergen.2024.12.002
PMID: 39700818
Contributors: Yang RK; Alvarez H; Lucas AS; Roy-Chowdhuri S; Rashid A; Chen H; Ballester LY; Sweeney K; Routbort MJ; Patel KP et al.
Source: Self-asserted source
Richard Yang

Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer Types

JCO Precision Oncology
2024-11 | Journal article
DOI: 10.1200/PO-24-00419
Contributors: Vijaykumar R. Holla; Michael P. Kahle; Sun-Hee Kim; Arash Ronaghy; Richard K. Yang; Keyur P. Patel; Mark J. Routbort; Michael J. Overman; Ecaterina E. Dumbrava; Kenna R. Mills Shaw et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Data from Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion

2024-11-15 | Preprint
DOI: 10.1158/1078-0432.c.7541185
Contributors: Mikayla B. Bowen; Brenda Melendez; Qian Zhang; Richard K. Yang; Bryan M. Fellman; Barrett C. Lawson; Naomi N. Adjei; Joseph Celestino; Khalida M. Wani; Bhavana Singh et al.
Source: check_circle
Crossref

Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion

Clinical Cancer Research
2024-11-15 | Journal article
DOI: 10.1158/1078-0432.CCR-24-0362
Contributors: Mikayla B. Bowen; Brenda Melendez; Qian Zhang; Richard K. Yang; Bryan M. Fellman; Barrett C. Lawson; Naomi N. Adjei; Joseph Celestino; Khalida M. Wani; Bhavana Singh et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion

2024-11-15 | Preprint
DOI: 10.1158/1078-0432.27754816
Contributors: Mikayla B. Bowen; Brenda Melendez; Qian Zhang; Richard K. Yang; Bryan M. Fellman; Barrett C. Lawson; Naomi N. Adjei; Joseph Celestino; Khalida M. Wani; Bhavana Singh et al.
Source: check_circle
Crossref

Supplementary Table S1 from Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion

2024-11-15 | Preprint
DOI: 10.1158/1078-0432.27754810
Contributors: Mikayla B. Bowen; Brenda Melendez; Qian Zhang; Richard K. Yang; Bryan M. Fellman; Barrett C. Lawson; Naomi N. Adjei; Joseph Celestino; Khalida M. Wani; Bhavana Singh et al.
Source: check_circle
Crossref

Supplementary Table S2 from Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion

2024-11-15 | Preprint
DOI: 10.1158/1078-0432.27754807
Contributors: Mikayla B. Bowen; Brenda Melendez; Qian Zhang; Richard K. Yang; Bryan M. Fellman; Barrett C. Lawson; Naomi N. Adjei; Joseph Celestino; Khalida M. Wani; Bhavana Singh et al.
Source: check_circle
Crossref

Supplementary Table S3 from Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion

2024-11-15 | Preprint
DOI: 10.1158/1078-0432.27754804
Contributors: Mikayla B. Bowen; Brenda Melendez; Qian Zhang; Richard K. Yang; Bryan M. Fellman; Barrett C. Lawson; Naomi N. Adjei; Joseph Celestino; Khalida M. Wani; Bhavana Singh et al.
Source: check_circle
Crossref

Supplementary Table S4 from Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion

2024-11-15 | Preprint
DOI: 10.1158/1078-0432.27754801
Contributors: Mikayla B. Bowen; Brenda Melendez; Qian Zhang; Richard K. Yang; Bryan M. Fellman; Barrett C. Lawson; Naomi N. Adjei; Joseph Celestino; Khalida M. Wani; Bhavana Singh et al.
Source: check_circle
Crossref

Utility of next‐generation sequencing in the diagnosis of metastatic melanoma: A case report

Journal of Cutaneous Pathology
2024-09 | Journal article
DOI: 10.1111/cup.14660
Contributors: Saul Turcios Escobar; Richard Yang; Kelly C. Nelson; Jeffrey E. Gershenwald; Hussein Tawbi; Phyu P. Aung; Sapna P. Patel; Carlos A. Torres‐Cabala
Source: check_circle
Crossref

BCR::ZNF711 and BCR::CYLC2 Fusions: Novel BCR Fusions Expanding the Molecular Spectrum of Gene Fusions in Melanoma

The American Journal of Dermatopathology
2024-07-12 | Journal article
DOI: 10.1097/dad.0000000000002796
Part of ISSN: 0193-1091
Contributors: Elsayed Ibrahim; Richard K. Yang; Jonathan L. Curry; Woo Cheal Cho
Source: Self-asserted source
Richard Yang

Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion

Journal of Cutaneous Pathology
2024-06 | Journal article
DOI: 10.1111/cup.14607
Contributors: Volha Lenskaya; Richard K. Yang; Woo Cheal Cho
Source: check_circle
Crossref

Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review

Journal of Cutaneous Pathology
2024-06 | Journal article
DOI: 10.1111/cup.14605
Contributors: Haneen T. Salah; Richard K. Yang; Sinchita Roy‐Chowdhuri; Merrick I. Ross; Phyu P. Aung; Aimi T. Rothrock; Carlos A. Torres‐Cabala; Jonathan L. Curry; Victor G. Prieto; Priyadharsini Nagarajan et al.
Source: check_circle
Crossref

Spitz Melanoma With SLC20A1::ALK Fusion: A Novel Fusion Previously Undescribed in Spitz Melanocytic Neoplasm

The American Journal of Dermatopathology
2024-06-28 | Journal article
DOI: 10.1097/dad.0000000000002778
Part of ISSN: 0193-1091
Contributors: Woo Cheal Cho; Victor G. Prieto; Richard K. Yang
Source: Self-asserted source
Richard Yang

Mitochondrial defects and metabolic vulnerabilities in Lynch syndrome-associated MSH2-deficient endometrial cancer

2024-06-11 | Preprint
DOI: 10.1101/2024.06.10.596841
Contributors: Mikayla Borthwick Bowen; Brenda Melendez; Qian Zhang; Diana Moreno; Leah Peralta; Wai Kin Chan; Collene Jeter; Lin Tan; M. Anna Zal; Philip L. Lorenzi et al.
Source: Self-asserted source
Richard Yang

Clinical and genomic landscape of RAS mutations in gynecologic cancers

Clinical Cancer Research
2024-04-30 | Journal article | Author
DOI: 10.1158/1078-0432.ccr-23-2819
Part of ISSN: 1078-0432
Part of ISSN: 1557-3265
Contributors: Ji Son; Yingao Zhang; Yan Lin; Mirallas, O; Pablo Alvarez-Ballesteros; Mirella Nardo; Natalie Clark; Robert Hillman; Erick Campbell; Vijaykumar Holla et al.
Source: Self-asserted source
Richard Yang

Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors

Cancers
2024-04-27 | Journal article
DOI: 10.3390/cancers16091707
Contributors: Ryan A. Denu; Cissimol P. Joseph; Elizabeth S. Urquiola; Precious S. Byrd; Richard K. Yang; Ravin Ratan; Maria Alejandra Zarzour; Anthony P. Conley; Dejka M. Araujo; Vinod Ravi et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Intragenic <i>EGFR::EGFR</i>.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors

Cancers
2023-12 | Journal article | Author
DOI: 10.3390/cancers16010006
Contributors: Lan Zheng; Rajyalakshmi Luthra; Hector A. Alvarez; F. Anthony San Lucas; Dzifa Y. Duose; Ignacio I. Wistuba; Gregory N Fuller; Leomar Y. Ballester; Sinchita Roy-Chowdhuri; Keith J. Sweeney et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes

Clinical Cancer Research
2023-12-01 | Journal article
DOI: 10.1158/1078-0432.CCR-23-1703
Contributors: Ryan A. Denu; Richard K. Yang; Alexander J. Lazar; Shalin S. Patel; Valerae O. Lewis; Jason Roszik; J. Andrew Livingston; Wei-Lien Wang; Kenna R. Shaw; Ravin Ratan et al.
Source: check_circle
Crossref

Data from Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals <i>TP53</i> Mutation to Be Associated with Worse Outcomes

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.c.6960592
Contributors: Ryan A. Denu; Richard K. Yang; Alexander J. Lazar; Shalin S. Patel; Valerae O. Lewis; Jason Roszik; J. Andrew Livingston; Wei-Lien Wang; Kenna R. Shaw; Ravin Ratan et al.
Source: check_circle
Crossref

Data from Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals <i>TP53</i> Mutation to Be Associated with Worse Outcomes

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.c.6960592.v1
Contributors: Ryan A. Denu; Richard K. Yang; Alexander J. Lazar; Shalin S. Patel; Valerae O. Lewis; Jason Roszik; J. Andrew Livingston; Wei-Lien Wang; Kenna R. Shaw; Ravin Ratan et al.
Source: check_circle
Crossref

Supplementary Figures 1-2 from Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals <i>TP53</i> Mutation to Be Associated with Worse Outcomes

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710491.v1
Contributors: Ryan A. Denu; Richard K. Yang; Alexander J. Lazar; Shalin S. Patel; Valerae O. Lewis; Jason Roszik; J. Andrew Livingston; Wei-Lien Wang; Kenna R. Shaw; Ravin Ratan et al.
Source: check_circle
Crossref

Supplementary Figures 1-2 from Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals <i>TP53</i> Mutation to Be Associated with Worse Outcomes

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710491
Contributors: Ryan A. Denu; Richard K. Yang; Alexander J. Lazar; Shalin S. Patel; Valerae O. Lewis; Jason Roszik; J. Andrew Livingston; Wei-Lien Wang; Kenna R. Shaw; Ravin Ratan et al.
Source: check_circle
Crossref

Supplementary Tables 1-2 from Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals <i>TP53</i> Mutation to Be Associated with Worse Outcomes

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710488
Contributors: Ryan A. Denu; Richard K. Yang; Alexander J. Lazar; Shalin S. Patel; Valerae O. Lewis; Jason Roszik; J. Andrew Livingston; Wei-Lien Wang; Kenna R. Shaw; Ravin Ratan et al.
Source: check_circle
Crossref

Supplementary Tables 1-2 from Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals <i>TP53</i> Mutation to Be Associated with Worse Outcomes

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710488.v1
Contributors: Ryan A. Denu; Richard K. Yang; Alexander J. Lazar; Shalin S. Patel; Valerae O. Lewis; Jason Roszik; J. Andrew Livingston; Wei-Lien Wang; Kenna R. Shaw; Ravin Ratan et al.
Source: check_circle
Crossref

15. Loss of MSH2 and MSH6 is frequently observed in prostate neoplasms with mismatch repair deficiency

Cancer Genetics
2023-11 | Journal article
DOI: 10.1016/j.cancergen.2023.08.023
Part of ISSN: 2210-7762
Contributors: Gokce Toruner; Richard Yang
Source: Self-asserted source
Richard Yang

Recurrent Somatic Copy Number Alterations and Their Association with Oncogene Expression Levels in High-Grade Ovarian Serous Carcinoma

Life
2023-11-10 | Journal article
DOI: 10.3390/life13112192
Contributors: Hillary P. Esplen; Richard K. Yang; Awdhesh Kalia; Zhenya Tang; Guilin Tang; L. Jeffrey Medeiros; Gokce A. Toruner
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant: Ascertained by Molecular Testing

Current Oncology
2023-10-05 | Journal article
DOI: 10.3390/curroncol30100651
Contributors: J. Bryan Iorgulescu; Leah K. Shaw; Asif Rashid; Priya Rao; Sreedhar Mandayam; Keyur P. Patel; Kathleen M. Schmeler; Richard K. Yang; Pavlos Msaouel
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Exploring the utility of liquid biopsy (ctDNA) as a translational endpoint in clinical trials for endometrial cancer (012)

Gynecologic Oncology
2023-09 | Journal article
DOI: 10.1016/j.ygyno.2023.06.478
Part of ISSN: 0090-8258
Contributors: Pamela Soliman; Richard Yang; Bryan Fellman; Taylor Taylor; Kelly Rangel; Shannon Westin; Karen Lu; Amir Jazaeri
Source: Self-asserted source
Richard Yang

Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization.

Cancer cytopathology
2023-09-25 | Journal article
DOI: 10.1002/cncy.22766
PMID: 37747438
Contributors: John Diks; Tang Z; Altan M; Anderson S; Chen H; Rashid A; Yang RK; Routbort MJ; Patel KP; Toruner GA et al.
Source: Self-asserted source
Richard Yang

All Supplemental Tables from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476422.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Data from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6529391.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplemental Figure SF-01 from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476419.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplemental Figure SF-02 from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476416.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplemental Figure SF-03 from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476413.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplemental Figure SF-04 from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476410.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplemental Figure SF-05 from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476407.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplemental Figure SF-06 from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476404.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplemental Figure SF-07 from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476401.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplemental Figure SF-08 from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476398.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplemental Figure SF-09 from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476395.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplemental Figure SF-10 from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476392.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplemental Figure SF-11 from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476389.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Supplemental Figure SF-12 from Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22476386.v1
Contributors: Richard K. Yang; Igor B. Kuznetsov; Erik A. Ranheim; Jun S. Wei; Sivasish Sindiri; Berkley E. Gryder; Vineela Gangalapudi; Young K. Song; Viharkumar Patel; Jacquelyn A. Hank et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎
Items per page:
Page 1 of 2
How many people are using ORCID?